simvastatin has been researched along with Bronchopulmonary Dysplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Chen, T; Fu, X; Huo, R; Li, L; Liang, Z; Lin, J; Lin, W; Pan, B; Wang, X; Xu, C | 1 |
| Allegaert, K; Berghen, N; de Winter, D; Deprest, J; Gie, A; Jimenez, J; Lesage, F; Salaets, T; Tack, B; Toelen, J | 1 |
2 other study(ies) available for simvastatin and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Simvastatin Inhibits NLRP3 Inflammasome Activation and Ameliorates Lung Injury in Hyperoxia-Induced Bronchopulmonary Dysplasia via the KLF2-Mediated Mechanism.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Antioxidants; Bronchopulmonary Dysplasia; Humans; Hyperoxia; Infant, Newborn; Inflammasomes; Inflammation; Kruppel-Like Transcription Factors; Lung; Lung Injury; NLR Family, Pyrin Domain-Containing 3 Protein; Simvastatin; Transcription Factors | 2022 |
Simvastatin attenuates lung functional and vascular effects of hyperoxia in preterm rabbits.
Topics: Animals; Bronchopulmonary Dysplasia; Female; Gene Expression Profiling; Hyperoxia; Pregnancy; Premature Birth; Rabbits; Random Allocation; Respiratory Function Tests; Simvastatin; Survival Analysis | 2020 |